Found 3 results

Author Title Type [ Year]

Filters: First Letter Of Title is C and Author is Treanor, J  [Clear All Filters]

2011

R. W. Frenck Jr, Belshe, R., Brady, R. C., Winokur, P. L., Campbell, J. D., Treanor, J., Hay, C. M., Dekker, C. L., Walter, E. B., Cate, T. R., Edwards, K. M., Hill, H., Wolff, M., Leduc, T., and Tornieporth, N., “Comparison of the Immunogenicity and Safety of a Split-Virion, Inactivated, Trivalent Influenza Vaccine (Fluzone®) Administered by Intradermal and Intramuscular Route in Healthy Adults”, Vaccine, vol. 29, no. 34, pp. 5666-5674, 2011.

2000

J. C. King, Treanor, J., Fast, P. E., Wolff, M. C., Yan, L., Iacuzio, D., Readmond, B., O’Brien, D., Mallon, K., Highsmith, W. E., Lambert, J. S., and Belshe, R. B., “Comparison of the safety, vaccine virus shedding and immunogenicity of influenza virus vaccine, trivalent, types A and B, live-cold-adapted (LAIV) administered to HIV-infected and non-HIV-infected adults”, J Infec Dis, vol. 181, pp. 725-8, 2000.

B. R. Belshe, Gruber, W. C., Mendelman, P. M., Mehta, H. B., Cho, I., Mahmood, K., Reisinger, K., Treanor, J., Zangwill, K., Hayden, F. G., Bernstein, D. I., Kotloff, K., King, J., Piedra, P. A., Block, S. L., Yan, L., and Wolff, M., “Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine”, J Infec Dis, vol. 181, pp. 11133-7, 2000.